{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:13:14Z","timestamp":1793214794183,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009053","name":"Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/M\/12\/1\/500261"],"award-info":[{"award-number":["IA\/M\/12\/1\/500261"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000732","name":"UK-india Education And Research Initiative","doi-asserted-by":"publisher","award":["P639"],"award-info":[{"award-number":["P639"]}],"id":[{"id":"10.13039\/501100000732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019550","name":"Scheme for Promotion of Academic and Research Collaboration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012913","name":"Tata Consultancy Services Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.lansea.2025.100593","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:56:12Z","timestamp":1747122972000},"page":"100593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India"],"prefix":"10.1016","volume":"37","author":[{"given":"Manash Pratim","family":"Gogoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandana","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyadeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-295X","authenticated-orcid":false,"given":"Gaurav","family":"Narula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Trehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7557-5816","authenticated-orcid":false,"given":"Venkatraman","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Tembhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4406-8299","authenticated-orcid":false,"given":"Man Updesh","family":"Singh Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-8702","authenticated-orcid":false,"given":"Anita","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Sundersingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shripad","family":"Banavali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-9649","authenticated-orcid":false,"given":"Vaskar","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6769-3847","authenticated-orcid":false,"given":"Shekhar","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lansea.2025.100593_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/pbc.21897","article-title":"Survival outcome in childhood ALL: experience from a tertiary care centre in North India","volume":"53","author":"Kulkarni","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.lansea.2025.100593_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26281","article-title":"Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India","volume":"64","author":"Trehan","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.lansea.2025.100593_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/0971-5851.171552","article-title":"Acute lymphoblastic leukemia: a single center experience with Berlin, Frankfurt, and Munster-95 protocol","volume":"36","author":"Radhakrishnan","year":"2015","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"5","key":"10.1016\/j.lansea.2025.100593_bib4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/bloodadvances.2020003526","article-title":"Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol","volume":"5","author":"Rajendra","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.lansea.2025.100593_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/1735-1995.178754","article-title":"Analysis of outcomes and prognostic factors of acute lymphoblastic leukemia patients treated by MCP841 protocol: a regional cancer center experience","volume":"21","author":"Kapoor","year":"2016","journal-title":"J Res Med Sci"},{"issue":"11","key":"10.1016\/j.lansea.2025.100593_bib6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.ejca.2004.11.004","article-title":"Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]","volume":"41","author":"Magrath","year":"2005","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.lansea.2025.100593_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13063-022-06033-1","article-title":"Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India","volume":"23","author":"Das","year":"2022","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.lansea.2025.100593_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1470-2045(22)00688-X","article-title":"Sex disparity in childhood cancer in India: a multi-centre, individual patient data analysis","volume":"24","author":"Bhatia","year":"2023","journal-title":"Lancet Oncol"},{"issue":"27","key":"10.1016\/j.lansea.2025.100593_bib9","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.2014.60.6376","article-title":"Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge","volume":"33","author":"Rodriguez-Galindo","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.lansea.2025.100593_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cyto.b.21939","article-title":"Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion","volume":"100","author":"Tembhare","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.lansea.2025.100593_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cyto.b.21486","article-title":"Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000","volume":"94","author":"Tembhare","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"12","key":"10.1016\/j.lansea.2025.100593_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27241","article-title":"Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin","volume":"65","author":"Vaishnavi","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.lansea.2025.100593_bib13","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1002\/cam4.5140","article-title":"Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India","volume":"12","author":"Mungle","year":"2023","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.lansea.2025.100593_bib14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1470-2045(23)00318-2","article-title":"Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis","volume":"24","author":"Ehrlich","year":"2023","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.lansea.2025.100593_bib15","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1634\/theoncologist.2015-0110","article-title":"Distance as a barrier to cancer diagnosis and treatment: review of the literature","volume":"20","author":"Ambroggi","year":"2015","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.lansea.2025.100593_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013059","article-title":"Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review","volume":"6","author":"Kelly","year":"2016","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.lansea.2025.100593_bib17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.bjc.6604895","article-title":"Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador","volume":"100","author":"Gupta","year":"2009","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.lansea.2025.100593_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjquality.u204420.w6531","article-title":"Chasing the Golden Hour - lessons learned from improving initial neutropenic sepsis management","volume":"6","author":"Forde","year":"2017","journal-title":"BMJ Qual Improv Rep"},{"issue":"3","key":"10.1016\/j.lansea.2025.100593_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1470-2045(12)70600-9","article-title":"Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial","volume":"14","author":"Vora","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.lansea.2025.100593_bib20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.19.01086","article-title":"Outcome in children with standard-risk B-cell acute lymphoblastic leukemia: results of children's oncology group trial AALL0331","volume":"38","author":"Maloney","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.lansea.2025.100593_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000782","article-title":"Clinical and prognostic impact of copy number alterations and associated risk profiles in a cohort of pediatric B-cell precursor acute lymphoblastic leukemia cases treated under ICiCLe protocol","volume":"6","author":"Gupta","year":"2022","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.lansea.2025.100593_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bjh.17494","article-title":"Influence of different asparaginase formulations in the prognosis of children with acute lymphocytic leukaemia in Brazil: a multicentre, retrospective controlled study","volume":"194","author":"Michalowski","year":"2021","journal-title":"Br J Haematol"},{"issue":"17","key":"10.1016\/j.lansea.2025.100593_bib23","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the children's oncology group","volume":"38","author":"Gupta","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.lansea.2025.100593_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ijc.33529","article-title":"Adequate asparaginase is important to prevent central nervous system and testicular relapse of pediatric Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia","volume":"149","author":"Liu","year":"2021","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.lansea.2025.100593_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29046","article-title":"Unsatisfactory quality of E. coli asparaginase biogenerics in India: implications for clinical outcomes in acute lymphoblastic leukaemia","volume":"68","author":"Sidhu","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.lansea.2025.100593_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12098-023-04687-6","article-title":"Maintenance treatment in acute lymphoblastic leukemia: a clinical primer","volume":"91","author":"Krishnan","year":"2024","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.lansea.2025.100593_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/jnci\/djae004","article-title":"Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations","volume":"116","author":"Maillard","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.lansea.2025.100593_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MPH.0000000000002796","article-title":"Hybrid email and outpatient clinics to optimize maintenance therapy in acute lymphoblastic leukemia","volume":"46","author":"Mungle","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.lansea.2025.100593_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooae089","article-title":"Analysis toolkit for evaluation of drug titration practice in acute lymphoblastic leukemia maintenance","volume":"7","author":"Mungle","year":"2024","journal-title":"JAMIA Open"},{"issue":"13","key":"10.1016\/j.lansea.2025.100593_bib30","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1182\/bloodadvances.2022007378","article-title":"High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse","volume":"6","author":"Short","year":"2022","journal-title":"Blood Adv"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368225000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368225000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:30:26Z","timestamp":1762644626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368225000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"alternative-id":["S2772368225000642"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2025.100593","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2025.100593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100593"}}